# Rubicon Biotechnology (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/rubicon-biotechnology-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 69 |
| Citations | 1,323 |
| City | Lake Forest |
| Country | United States |
| Description | Rubicon Biotechnology (United States) is a research organisation in Lake Forest, United States. OpenAlex records 46 works and 1,323 citations for it. 1 researchers list it as their most recent affiliation. |
| Homepage | https://rubiconbio.com/ |
| OpenAlex ID | https://openalex.org/I4210104612 |
| Region | California |
| Researchers | 1 |
| ROR ID | https://ror.org/027fvmc90 |
| Type | company |
| Works | 46 |

## University papers

- [Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus](https://scholariq.org/papers/maternal-plasma-dna-sequencing-reveals-the-genome-wide-genetic-and-mutational/)
- [Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma](https://scholariq.org/papers/noninvasive-prenatal-diagnosis-of-fetal-chromosomal-aneuploidy-by-massively/)
- [Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments](https://scholariq.org/papers/plasma-dna-tissue-mapping-by-genome-wide-methylation-sequencing-for-noninvasive/)
- [Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study](https://scholariq.org/papers/non-invasive-prenatal-assessment-of-trisomy-21-by-multiplexed-maternal-plasma/)
- [Size Distributions of Maternal and Fetal DNA in Maternal Plasma](https://scholariq.org/papers/size-distributions-of-maternal-and-fetal-dna-in-maternal-plasma/)
- [Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)](https://scholariq.org/papers/antitumor-activity-of-nivolumab-in-recurrent-and-metastatic-nasopharyngeal/)
- [Microfluidics Digital PCR Reveals a Higher than Expected Fraction of Fetal DNA in Maternal Plasma](https://scholariq.org/papers/microfluidics-digital-pcr-reveals-a-higher-than-expected-fraction-of-fetal-dna/)
- [Plasma DNA End-Motif Profiling as a Fragmentomic Marker in Cancer, Pregnancy, and Transplantation](https://scholariq.org/papers/plasma-dna-end-motif-profiling-as-a-fragmentomic-marker-in-cancer-pregnancy-and/)
- [Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma](https://scholariq.org/papers/noninvasive-prenatal-diagnosis-of-monogenic-diseases-by-digital-size-selection/)
- [Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing](https://scholariq.org/papers/noninvasive-prenatal-diagnosis-of-fetal-trisomy-18-and-trisomy-13-by-maternal/)
- [Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing](https://scholariq.org/papers/size-based-molecular-diagnostics-using-plasma-dna-for-noninvasive-prenatal/)
- [Digital PCR Analysis of Maternal Plasma for Noninvasive Detection of Sickle Cell Anemia](https://scholariq.org/papers/digital-pcr-analysis-of-maternal-plasma-for-noninvasive-detection-of-sickle-cell/)

## University researchers

- [K.C. Allen Chan](https://scholariq.org/researchers/k-c-allen-chan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.